ReviewEuropean cardiology2026
Alcohol, the Mediterranean Diet and Cardiovascular Risks: Where is the New Evidence?
Review in European cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mediterranean diet has consistently shown associations with lower risks of cardiovascular disease (CVD) in randomised controlled trials and large prospective cohorts. Traditionally, moderate wine consumption was considered part of the Mediterranean diet. However, whether low-to-moderate alcohol intake contributes independently to lower risk remains controversial. Early epidemiological reports supported a J-shaped association between alcohol intake and CVD, but residual confounding, selection biases or misclassification of former drinkers challenge causal interpretations. Methodological limitations, particularly the inability to capture drinking patterns, have also been raised in recent assessments of the Global Burden of Disease and Mendelian randomisation studies. A more nuanced view may be that low-to-moderate wine consumption in older adults is not likely to be harmful but alcohol should not be recommended for CVD prevention. Large-scale randomised trials, such as the ongoing UNATI study, are expected to clarify the impact of moderate drinking versus abstention. Meanwhile, clinical guidance should emphasise the proven cardiometabolic benefits of the Mediterranean diet overall independent of alcohol consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.